- Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography
- Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024
- Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic Testing
- Hologic to Unveil Groundbreaking AI Research at ECR 2024
- Hologic to Webcast Presentations at Upcoming Investor Conferences
- Hologic Announces First and Only FDA-Cleared Digital Cytology System – Genius™ Digital Diagnostics System
- Hologic Announces Financial Results for First Quarter of Fiscal 2024
More ▼
Key statistics
On Friday, Hologic Inc (HOLX:NSQ) closed at 76.37, -13.10% below its 52-week high of 87.88, set on May 01, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 75.23 |
---|---|
High | 76.61 |
Low | 75.14 |
Bid | 76.37 |
Offer | 76.38 |
Previous close | 75.71 |
Average volume | 1.47m |
---|---|
Shares outstanding | 234.73m |
Free float | 233.00m |
P/E (TTM) | 35.99 |
Market cap | 17.77bn USD |
EPS (TTM) | 2.10 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 20:46 BST.
More ▼